{"name": "Prolong Pharmaceuticals",
 "permalink": "prolong-pharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/prolong-pharmaceuticals",
 "homepage_url": "http://www.prolongpharmaceuticals.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@prolongpharma.com",
 "phone_number": "908-444-4660",
 "description": "",
 "created_at": "Wed Oct 20 07:19:38 UTC 2010",
 "updated_at": "Wed Oct 20 07:19:37 UTC 2010",
 "overview": "\u003Cp\u003EProlong Pharmaceuticals, Inc. develops and markets biopharmaceutical products. Its products include PEG-uricase for the treatment of hyperuricemia; PEG-arginase for the treatment of melanoma and hepatocellular carcinoma; PEG-protein for the treatment of hypovolemic shock; PEG-peptide antibiotic to treat staphylococcus infections; PEG-streptokinase for myocardial infarcts; anti-cancer agents; and Erythropoietin, a biopharmaceutical that provides a solution for anemia. The company also offers custom manufacturing services; and licenses its products to pharmaceutical companies. Prolong Pharmaceuticals, Inc. was founded in 2002 and is based in New Jersey.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       34],
      "assets/images/resized/0010/6338/106338v1-max-150x150.png"],
     [[250,
       57],
      "assets/images/resized/0010/6338/106338v1-max-250x250.png"],
     [[300,
       69],
      "assets/images/resized/0010/6338/106338v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$30M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.fiercebiotech.com/story/prolong-pharma-lands-30m-investors/2010-10-14?utm_medium=rss\u0026utm_source=rss",
    "source_description": "Prolong Pharma lands $30M from investors",
    "raised_amount": 30000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 10,
    "funded_day": 14,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "300 Corporate Court",
    "address2": "Middlesex Business Center",
    "zip_code": "07080",
    "city": "South Plainfield",
    "state_code": "NJ",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}